Search research articles
Contact Us
Filters
Showing results (181-190 of 275) with videos related to
Page
of 28
Sort By:
Clinical Pharmacology and Therapeutics
|
August 1, 1979
Plasma clearance of propranolol and sotalol and hepatic drug-metabolizing enzyme activity
E A Sotaniemi, M Anttila, R O Pelkonen, et al.
Biochemical Pharmacology
|
April 1, 1979
Formation of benzo[a]pyrene metabolite-nucleoside adducts in isolated perfused rat and mouse liver and in mouse lung slices
G F Kahl, E Klaus, C Legraverend, et al.
European Journal of Clinical Pharmacology
|
March 17, 1978
Liver size and indices of drug metabolism in alcoholics
H I Pirttiaho, E A Sotaniemi, J Ahlqvist, et al.
Journal of Human Hypertension
|
September 25, 2003
Associations of blood pressure with carotid intima-media thickness in elderly Finns with diabetes mellitus or impaired glucose tolerance
U Rajala, M Päivänsalo, M Laakso, et al.
Gene
|
June 14, 1995
Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility--a review
H Raunio, K Husgafvel-Pursiainen, S Anttila, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1995
Antipyrine, coumarin and glipizide affect n-acetylation measured by caffeine test
I Klebovich, A Rautio, P Salonpää, et al.
European Journal of Clinical Pharmacology
|
January 1, 1982
Plasma high-density lipoproteins and hepatic microsomal enzyme induction. Relation to histological changes in the liver
P V Luoma, E A Sotaniemi, R O Pelkonen, et al.
Epilepsia
|
November 1, 1994
Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine
J I Isojärvi, A J Pakarinen, A Rautio, et al.
British Journal of Clinical Pharmacology
|
January 1, 1978
Drug metabolism in epileptics: in vivo and in vitro correlations
E A Sotaniemi, R O Pelkonen, J Ahokas, et al.
Toxicology
|
November 14, 1997
Hepatitis A impairs the function of human hepatic CYP2A6 in vivo
M Pasanen, Z Rannala, A Tooming, et al.
Page
of 28
Search research articles
Search
Showing results (181-190 of 275) with videos related to
Sort By:
Page
of 28
Clinical Pharmacology and Therapeutics
|
August 1, 1979
Plasma clearance of propranolol and sotalol and hepatic drug-metabolizing enzyme activity
E A Sotaniemi, M Anttila, R O Pelkonen, et al.
Biochemical Pharmacology
|
April 1, 1979
Formation of benzo[a]pyrene metabolite-nucleoside adducts in isolated perfused rat and mouse liver and in mouse lung slices
G F Kahl, E Klaus, C Legraverend, et al.
European Journal of Clinical Pharmacology
|
March 17, 1978
Liver size and indices of drug metabolism in alcoholics
H I Pirttiaho, E A Sotaniemi, J Ahlqvist, et al.
Journal of Human Hypertension
|
September 25, 2003
Associations of blood pressure with carotid intima-media thickness in elderly Finns with diabetes mellitus or impaired glucose tolerance
U Rajala, M Päivänsalo, M Laakso, et al.
Gene
|
June 14, 1995
Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility--a review
H Raunio, K Husgafvel-Pursiainen, S Anttila, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1995
Antipyrine, coumarin and glipizide affect n-acetylation measured by caffeine test
I Klebovich, A Rautio, P Salonpää, et al.
European Journal of Clinical Pharmacology
|
January 1, 1982
Plasma high-density lipoproteins and hepatic microsomal enzyme induction. Relation to histological changes in the liver
P V Luoma, E A Sotaniemi, R O Pelkonen, et al.
Epilepsia
|
November 1, 1994
Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine
J I Isojärvi, A J Pakarinen, A Rautio, et al.
British Journal of Clinical Pharmacology
|
January 1, 1978
Drug metabolism in epileptics: in vivo and in vitro correlations
E A Sotaniemi, R O Pelkonen, J Ahokas, et al.
Toxicology
|
November 14, 1997
Hepatitis A impairs the function of human hepatic CYP2A6 in vivo
M Pasanen, Z Rannala, A Tooming, et al.
Page
of 28